Abstract: Provided is foley catheter and a composition for producing a foley catheter which is inserted in vivo and a method for producing the same, which the composition consists of the materials which carbon nanotube polymer (CNT Polymer) bonded a carbon nanotube and zinc oxide (ZnO) is combined with a silicon, wherein from 1.0 to 2.2 parts by weight of the said carbon nanotube polymer are combined with 100 parts by weight of silicon.

Abstract: The present invention relates to a coral composite extract, a composition including the same and a method of producing the same. The coral composite extract includes at least two briarane-type diterpenoid compounds from corals of Briareum violaceum, B. excavatum and B. stechei, thereby being applied as an effective ingredient of a skin external use composition, a cosmetic composition and a medicinal composition.

Abstract: The present invention relates to pharmaceutical compositions comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent or a derivative or pharmaceutically acceptable salt thereof. The present invention also relates to methods of inhibiting cancer cell growth while reducing toxicity, comprising administering the pharmaceutical composition described herein.

Abstract: The present invention relates to pharmaceutical compositions comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent or a derivative or pharmaceutically acceptable salt thereof. The present invention also relates to methods of inhibiting cancer cell growth while reducing toxicity, comprising administering the pharmaceutical composition described herein.

Abstract: The present invention relates a composition for producing a foley catheter which is inserted in vivo and a method for producing the same, which the composition consists of the materials which carbon nanotube polymer (CNT Polymer) bonded a carbon nanotube and zinc oxide (ZnO) is combined with a silicon, wherein from 1.0 to 2.2 parts by weight of the said carbon nanotube polymer are combined with 100 parts by weight of silicon.

Abstract: Provided is a foley catheter and a method of manufacturing the same, it is characterized in that the foley catheter comprises a catheter body made of a material which a carbon nanotube polymer (CNT Polymer) bonded a carbon nanotube and zinc oxide (ZnO) is combined with a silicon; and a foley for catheter that are made of a material which a carbon nanotube polymer (CNT Polymer) bonded a carbon nanotube and zinc oxide (ZnO) is combined with a silicon, and are bonded to the catheter body so as to be inflated by a fluid introduced from the outside; wherein the mixing ratio of the carbon nanotube polymer of the said foley for catheter is higher than that of the carbon nanotube polymer of the said catheter body.

Abstract: A Y-type gauze positioning rod is adapted to be disposed in a Y-type gauze so as to position the Y-type gauze to an affected region. The Y-type gauze positioning rod includes a Y-type flexible body having a holder and two supporting branches. The two supporting branches are connected to the holder and separated from each other. A Y-type gauze positioning assembly is further provided.

Abstract: The present invention relates to a method for treating pain in a subject in need thereof, comprising administering an effective amount of a nucleic acid to the subject, wherein the nucleic acid comprises a PTEN nucleotide sequence of SEQ ID NO: 1. The present invention also provides a method for screening pharmaceutical compositions having an anti-pain effect, wherein the pharmaceutical compositions can stimulate the upregulation of PTEN.

Abstract: A Y-type gauze positioning rod is adapted to be disposed in a Y-type gauze so as to position the Y-type gauze to an affected region. The Y-type gauze positioning rod includes a Y-type flexible body having a holder and two supporting branches. The two supporting branches are connected to the holder and separated from each other. A Y-type gauze positioning assembly is further provided.

Abstract: The present invention relates to pharmaceutical compositions comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent or a derivative or pharmaceutically acceptable salt thereof. The present invention also relates to methods of inhibiting cancer cell growth while reducing toxicity, comprising administering the pharmaceutical composition described herein.

Abstract: The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.

Abstract: The present invention relates to a method for modulating angiogenesis in a subject in need thereof, which comprises administering an effective amount of composition comprising excavatolide B and a pharmaceutically acceptable carrier to the subject.

Abstract: The present invention relates to a method for treating pain in a subject in need thereof, comprising administering an effective amount of a nucleic acid to the subject, wherein the nucleic acid comprises a PTEN nucleotide sequence of SEQ ID NO: 1. The present invention also provides a method for screening pharmaceutical compositions having an anti-pain effect, wherein the pharmaceutical compositions can stimulate the upregulation of PTEN.

Abstract: The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.

Abstract: Provided is an embedded active actuator drive system. In an actuator drive system for controlling an actuator for operating an actuator material that is sensitised to a human body, provided is an embedded active actuator drive system that can actively control an actuator mounted in the particular smart sheet according to bio-signal information that is detected in real-time by linking with a database drive information about driving the actuator that is mounted in the particular smart sheet and that operates the actuator material sensitised to a human body.

Abstract: A method for allowing and managing user equipment to connect to wireless local network from cellular network via a femtocell is provided. The method includes the steps of: broadcasting an RF signal within a predetermined area to allow the user equipment within the predetermined area to register with the femtocell; broadcasting a paging signal to search for at least one hotspot within a wireless cellular network coverage area when the user equipment has registered with the femtocell; establishing a connection between the femtocell and a found hotspot; sending a request to the found hotspot for obtaining connection information; sending the connection information to the user equipment registered with the femtocell, allowing the user equipment to access the wireless local area network via the found hotspot.

Abstract: A snow protection device mainly includes a piece of waterproof cloth, two bars, and at least two rubber magnets. The waterproof cloth includes a piece of cloth that is light-weighted, windable, and resistant against penetration of water. The two bars are respectively mounted to opposite side edges of the waterproof cloth. The rubber magnets are of magnetic attraction and are flexible and are arranged on the waterproof cloth at locations adjacent to and beside the bars. As such, the two bars can be used to collapse and expand the waterproof cloth and the rubber magnets may be securely attached, by means of magnetic attraction, to locations around a windshield so as to securely hold the waterproof cloth in position. The waterproof cloth is thus set to shield and cover the windshield. The resistance against water penetration of the waterproof cloth prevents water from contacting and being frozen on the windshield.

Abstract: A snow protection device mainly includes a piece of waterproof cloth, two bars, and at least two rubber magnets. The waterproof cloth includes a piece of cloth that is light-weighted, windable, and resistant against penetration of water. The two bars are respectively mounted to opposite side edges of the waterproof cloth. The rubber magnets are of magnetic attraction and are flexible and are arranged on the waterproof cloth at locations adjacent to and beside the bars. As such, the two bars can be used to collapse and expand the waterproof cloth and the rubber magnets may be securely attached, by means of magnetic attraction, to locations around a windshield so as to securely hold the waterproof cloth in position. The waterproof cloth is thus set to shield and cover the windshield. The resistance against water penetration of the waterproof cloth prevents water from contacting and being frozen on the windshield.

Abstract: A system for calculating trace lengths of a PCB layout includes a computer (10) and a database (11). The computer includes: an object setting module (100) for setting objects to define section rules; a section rule defining module (101) for selecting objects as a start point and an end point for each section in a section rule, and defining a length for the section; a trace selecting module (102) for selecting traces from a trace class; a trace calculating module (103) for calculating all lengths of sections contained in each selected trace and a total length of the selected trace, and determining whether all the selected traces have been calculated; an information generating module (104) for generating corresponding notices if necessary; a storing module (105) for storing the section rules and calculation results; and a calculation result converting module (106) for converting the calculation results into a designated data file.

Abstract: A system for calculating trace lengths of a PCB layout includes a computer (10) and a database (11). The computer includes: an object setting module (100) for setting objects to define section rules; a section rule defining module (101) for selecting objects as a start point and an end point for each section in a section rule, and defining a length for the section; a trace selecting module (102) for selecting traces from a trace class; a trace calculating module (103) for calculating all lengths of sections contained in each selected trace and a total length of the selected trace, and determining whether all the selected traces have been calculated; an information generating module (104) for generating corresponding notices if necessary; a storing module (105) for storing the section rules and calculation results; and a calculation result converting module (106) for converting the calculation results into a designated data file.